Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function

  • Authors:
    • Charlotte von Bülow
    • Leticia Oliveira‑Ferrer
    • Thomas Löning
    • Fabian Trillsch
    • Sven Mahner
    • Karin Milde‑Langosch
  • View Affiliations

  • Published online on: July 1, 2015     https://doi.org/10.3892/mco.2015.593
  • Pages: 1067-1072
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cadherin-11 (CDH11, OB-cadherin) is a mesenchymal cadherin found to be upregulated in various types of tumors and implicated in tumor progression and metastasis. In order to determine the role of CDH11 expression in ovarian tumors, we performed a combined reverse transcription quantitative polymerase chain reaction (RT‑qPCR), western blot analysis and immunohistochemical study on a large cohort of benign, borderline and invasive ovarian tumors. The RT‑qPCR and western blot analysis demonstrated that the CDH11 expression was high in benign cystadenomas and decreased with increasing malignancy. This may be explained by the different tumor‑stroma ratios, since immunohistochemistry revealed strong staining of stromal cells, particularly vascular smooth muscle cells and endothelial cells, but only weak cytoplasmic or nuclear immunoreactivity of cancer cells. Within the group of invasive carcinomas, high CDH11 protein expression, as detected by western blot analysis, was found to be significantly correlated with advanced stage and nodal involvement. However, the recurrence-free and overall survival analyses did not reveal any prognostic or predictive significance. In conclusion, in contrast to other tumor types, CDH11 does not play an important role in ovarian cancer progression.
View Figures
View References

Related Articles

Journal Cover

September-2015
Volume 3 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
von Bülow C, Oliveira‑Ferrer L, Löning T, Trillsch F, Mahner S and Milde‑Langosch K: Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function. Mol Clin Oncol 3: 1067-1072, 2015.
APA
von Bülow, C., Oliveira‑Ferrer, L., Löning, T., Trillsch, F., Mahner, S., & Milde‑Langosch, K. (2015). Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function. Molecular and Clinical Oncology, 3, 1067-1072. https://doi.org/10.3892/mco.2015.593
MLA
von Bülow, C., Oliveira‑Ferrer, L., Löning, T., Trillsch, F., Mahner, S., Milde‑Langosch, K."Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function". Molecular and Clinical Oncology 3.5 (2015): 1067-1072.
Chicago
von Bülow, C., Oliveira‑Ferrer, L., Löning, T., Trillsch, F., Mahner, S., Milde‑Langosch, K."Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function". Molecular and Clinical Oncology 3, no. 5 (2015): 1067-1072. https://doi.org/10.3892/mco.2015.593